The current landscape of diabetes management in Morocco predominantly involves conventional pharmacological treatments, such as insulin and oral hypoglycemic agents (e.g., metformin, sulfonylureas), commonly prescribed for type 2 diabetes [364]. The gene discussed is INS; the disease is diabetes mellitus.